Ga verder naar de inhoud

General Annual Meeting (GAM)

This folder contains all the recordings of the GAM.

BHS 2022

Advances in Laboratory Technology

Presenters: Ann De Becker, UZ Brussel, Belgium and Ine Moors, UZ Gent, Belgium - Feb 4, 2022

Chairs: Ivan Van Riet & Helena Devos

CHIP, CHOP, ARCH: lost in translation

Ann De Becker, UZ Brussel, Belgium

Genetic predisposition in myeloid malignancies

Ine Moors, UZ Gent, Belgium

Read more
BHS 2022

Highlight 1

Presenter: Jean-Jaques Kiladjian, Hôpital Saint Louis - Feb 4, 2022

Chairs: Timothy Devos & Dominiek Mazure

Management of myelofibrosis: novel approaches and recent evolutions

Jean-Jaques Kiladjian, Hôpital Saint Louis Paris, France

Read more
BHS 2022

Welcome

Presenter: Ann Janssens, BHS President - Feb 4, 2022

Ann Janssens, BHS President

Read more
BHS GAM hub

FLT3m+ AML

Speaker: Dimitri Breems, ZNA Antwerpen, Belgium, Chairs: Ann Janssens & Dimitri Breems - Jan 30, 2021

Session title: Satellite 3 – Astellas: Reshaping the Management of FLT3m+ AML
with New Targeted Agents

11:30 - 12:30, 30 January, 36th General Annual Meeting

Language: English

Read more
BHS GAM hub

FLT3 Diagnostics: which Test for which Patients?

Speaker: Lucienne Michaux, UZ Leuven & KU Leuven, Belgium, Chairs: Ann Janssens & Dimitri Breems - Jan 30, 2021

Session title: Satellite 3 – Astellas: Reshaping the Management of FLT3m+ AML
with New Targeted Agents

11:30 - 12:30, 30 January, 36th General Annual Meeting

Language: English

Read more
BHS GAM hub

FLT3 Targeted Therapies (1st line and R/R)

Speaker: Sébastian Anguille, UZ Antwerpen, Belgium, Chairs: Ann Janssens & Dimitri Breems - Jan 30, 2021

Session title: Satellite 3 – Astellas: Reshaping the Management of FLT3m+ AML
with New Targeted Agents

11:30 - 12:30, 30 January, 36th General Annual Meeting

Language: English

Read more
BHS GAM hub

Liquid Biopsies for Hodgkin and DLBCL (differential) Diagnosis

Speaker: Jo Van Dorpe, UZ Gent, Belgium, Chairs: Helena Devos & Marc André - Jan 30, 2021

Laboratory Session at GAM 2021 in collaboration with the Belgian Society of Pathology

11:30 - 12:30, 30 January, 36th General Annual Meeting

Language: English

Read more
BHS GAM hub

Which RIC for which AML Patient

Speaker: Frédéric Baron, University of Liège, Belgium, Chairs: Philippe Lewalle & Sophie Servais - Jan 30, 2021

Session title: Highlights on Malignant Hematology Part 2

10:30 - 11:00, 30 January, 36th General Annual Meeting

Language: English

Read more
BHS GAM hub

MM and Immune Related Therapies

Speaker: Maria Victoria Mateos, University Hospital of Salamanca, Spain, Chairs: Ivan Van Riet & Valerie Robin - Jan 30, 2021

Session title: Highlights on Malignant Hematology Part 1

10:00 - 10:30, 30 January, 36th General Annual Meeting

Language: English

Read more
BHS GAM hub

Treatment in very Elderly DLBCL Patients: Hopes and Caveats.

André Bosly, UCL Namur Godinne, Belgium - Jan 30, 2021

Session title: Satellite 2 – Roche : What does the Future hold for Patients with DLBCL?

09:00 - 10:00, 30 January, 36th General Annual Meeting

Language: English

Read more
BHS GAM hub

Can Novel Therapies Improve Outcomes for Patients with DLBCL?

Speaker: Sascha Dietrich, Universitätsklinikum Heidelberg, Germany, Chairs: Ann Janssens & Helena Devos - Jan 30, 2021

Session title: Satellite 2 – Roche : What does the Future hold for Patients with DLBCL?

09:00 - 10:00, 30 January, 36th General Annual Meeting

Language: English

Read more
BHS GAM hub

COVID-19, a Year Later

Speaker: Erika Vlieghe, UZ Antwerpen, Belgium, Chairs: Ann Janssens & Marc André - Jan 29, 2021

Session title: Ethics & Economy

17:00 - 18:00, 29 January, 36th General Annual Meeting

Language: English

Read more